Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 19/20 | 0.52 |
| ▸ | CA1 | P00915 | 15/20 | 0.52 |
| ▸ | CA7 | P43166 | 7/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.52 |
| ▸ | CA9 | Q16790 | 6/20 | 0.51 |
| ▸ | CA4 | P22748 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2476366 | 0.94 | CA2 (0.50) | CA2CA1CA7CA14CA9 | |
| SCHEMBL27466843 | 0.84 | CA2 (0.50) | CA2CA1CA7CA14CA9 | |
| SCHEMBL675017 | 0.80 | MMP9 (0.56) | CA2CA1 | |
| SCHEMBL9395046 | 0.80 | MMP9 (0.56) | CA2CA1 | |
| SCHEMBL9450366 | 0.79 | CA2 (0.56) | CA2CA1CA7CA14CA9 | |
| SCHEMBL528414 | 0.79 | EPHX1 (0.56) | CA2CA1 | |
| SCHEMBL7027498 | 0.79 | MMP3 (0.47) | CA2CA1 | |
| Hydrochloric Acid SCHEMBL31092601 | 0.78 | EPHX1 (0.54) | CA2CA1 | |
| SCHEMBL27495544 | 0.77 | MMP13 (0.53) | CA2CA1 | |
| SCHEMBL6340363 | 0.77 | TDP1 (0.43) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2373622-A2 | CA-IX SPECIFIC RADIOPHARMACEUTICALS FOR THE TREATMENT AND IMAGING OF CANCER | Molecular Insight Pharmaceuticals, Inc. (US) | 2011-10-12 | — | — | EP | disclosed |